HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Sideroblastic anemia as a preleukemic event in patients treated for Hodgkin's disease.

AbstractSideroblastic anemia after treatment for Hogdkin's disease was seen in two patients 3 years after completion of radiation therapy and chemotherapy. This was followed in both by the development of myelomonoblastic leukemia. No evidence of recurrent Hodgkin's disease was present in either patient. Our observation suggests that development of sideroblastic anemia in patients previously treated for Hodgkin's disease is probably secondary to the treatment and is a preleukemic event.
AuthorsM Kitahara, T M Cosgriff, H J Eyre
JournalAnnals of internal medicine (Ann Intern Med) Vol. 92 Issue 5 Pg. 625-7 (May 1980) ISSN: 0003-4819 [Print] UNITED STATES
PMID6770730 (Publication Type: Case Reports, Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antineoplastic Agents
Topics
  • Adult
  • Anemia, Sideroblastic (diagnosis, etiology)
  • Antineoplastic Agents (adverse effects)
  • Drug Therapy, Combination
  • Hodgkin Disease (complications, therapy)
  • Humans
  • Leukemia, Myeloid, Acute (diagnosis, etiology)
  • Male
  • Middle Aged
  • Preleukemia (diagnosis)
  • Radiotherapy, High-Energy (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD